Business · 17/12/2015
FDA Announces Meeting on Interface of Regulatory and Analytical Sciences for Biotechnology Health Products
The FDA is hosting a meeting to discuss the development of biotechnology-derived drug products and the analytic methodologies needed for their development, in collaboration with the International Separation Science Society (CASSS).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →